The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

These include prescription drugs, physical therapy ... a popular choice for people with neuropathy, as they can help reduce pain and inflammation, improve nerve function, and promote overall ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Neuropathy, or nerve dysfunction ... with less potential side effects than traditional pain medication. “I did notice that I felt less back and body pain when lying down towards the end of ...

Platinum-based or taxane chemotherapy drugs appear to pose the greatest risk for nerve pain, and lung cancer patients seem to have the highest rates of neuropathy, results show. Chemo drugs kill ...